TRIFERIC

Serial Number 86036014
Registration 4837260
702

Registration Progress

Application Filed
Aug 13, 2013
Under Examination
Mar 4, 2014
Approved for Publication
Jan 7, 2014
Published for Opposition
Jan 7, 2014
Registered
Oct 20, 2015

Attorney Assistance

Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20151020) (Grace Period Filing)
Due: Apr 20, 2026 Grace Period - 109 days
Original deadline was Oct 20, 2025 (overdue)

Trademark Image

TRIFERIC

Basic Information

Serial Number
86036014
Registration Number
4837260
Filing Date
August 13, 2013
Registration Date
October 20, 2015
Published for Opposition
January 7, 2014
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Jun 1, 2021
Registration
Registered
Classes
005

Rights Holder

ROCKWELL MEDICAL, INC.

03
Address
30142 WIXOM ROAD
WIXOM, MI 48393

Ownership History

ROCKWELL MEDICAL, INC.

Original Applicant
03
Wixom, MI

ROCKWELL MEDICAL, INC.

Owner at Publication
03
Wixom, MI

ROCKWELL MEDICAL, INC.

Original Registrant
03
Wixom, MI

ROCKWELL MEDICAL, INC.

New Owner After Registration #1
03
WIXOM, MI

Legal Representation

Attorney
Matthew J. Gipson

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20151020)
Due Date
October 20, 2025
Grace Period Ends
April 20, 2026

Application History

34 events
Date Code Type Description Documents
Oct 20, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jun 1, 2021 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jun 1, 2021 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jun 1, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jan 29, 2021 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 20, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Oct 20, 2020 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 20, 2015 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 16, 2015 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 15, 2015 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 5, 2015 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 3, 2015 IUAF S USE AMENDMENT FILED Loading...
Sep 3, 2015 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 10, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 7, 2015 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 2, 2015 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 2, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 17, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 16, 2014 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 2, 2014 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 16, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 2, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 4, 2014 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 7, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 7, 2014 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 18, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 3, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 29, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 29, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 30, 2013 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Oct 25, 2013 ALIE A ASSIGNED TO LIE Loading...
Oct 24, 2013 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Aug 21, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 16, 2013 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
preparations for use in clinical and medical dialysis procedures; pharmaceutical solutions used in dialysis and hemodialysis; pharmaceutical preparations, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; pharmaceutical preparations for injection, namely, preparations for treating iron deficiency, anemia, kidney disease and renal disease; iron delivery therapy, namely, commercial iron nutritional supplements, intravenous fluids used for the delivery of iron and soluble ferric pyrophosphate
First Use Anywhere: Sep 3, 2015
First Use in Commerce: Sep 3, 2015

Classification

International Classes
005